Evolent Health Inc - Ordinary Shares - Class A
EVH
Get informed when a big investor buys or sells
+ FollowMarket Cap$539.91M
Close$
$7.40
54.2% upside
Current Fair Value
54.2% upsideUndervalued by 54.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $539.91 Million |
|---|---|
| Enterprise Value | $429.38 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-5.07 |
| Beta | 0.84 |
| Outstanding Shares | 112,542,000 |
Return
| Return on Equity | -133.36% |
|---|---|
| Return on Assets | -25.92% |
| Return on Invested Capital | -34.19% |
Valuation & Multiples
| P/E Ratio | -1.07 |
|---|---|
| PEG | 2.4 |
| Price to Sales | 0.34 |
| Price to Book Ratio | 1.6 |
| Enterprise Value to Revenue | 0.27 |
| Enterprise Value to EBIT | -0.85 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$-0.01
Average shareholder expectationRevenue Estimate
$597.69 M
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$0.06
Average shareholder expectationRevenue Estimate
$727.06 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 133.63% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.62%▼ 101.06% |
|---|---|
| Total Invested | $2.45M▼ 99.61% |
| Investors Holding | 20▼ 187.00% |
ESG Score
No data
About Evolent Health Inc
CEO: Frank Williams